MKTX vs REPL
MarketAxess Holdings Inc (MKTX) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
REPL does not have a complete income-statement cache yet.
MKTX currently screens at market cap $4.00B and trailing P/E 13.3. REPL currently screens at market cap $825.7M.
Not investment advice. Open the MKTX and REPL stock pages for the full models.
Not investment advice.